Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $106.52 million. The enterprise value is $77.53 million.
Important Dates
The last earnings date was Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 81.94 million shares outstanding. The number of shares has increased by 75.88% in one year.
| Current Share Class | 81.94M |
| Shares Outstanding | 81.94M |
| Shares Change (YoY) | +75.88% |
| Shares Change (QoQ) | +11.40% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 38.39% |
| Float | 81.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 32.45 |
| PB Ratio | 17.63 |
| P/TBV Ratio | 17.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 1.43.
| Current Ratio | 1.04 |
| Quick Ratio | 0.99 |
| Debt / Equity | 1.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -296.36% and return on invested capital (ROIC) is -135.41%.
| Return on Equity (ROE) | -296.36% |
| Return on Assets (ROA) | -76.36% |
| Return on Invested Capital (ROIC) | -135.41% |
| Return on Capital Employed (ROCE) | -706.27% |
| Weighted Average Cost of Capital (WACC) | 11.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$758,339 |
| Employee Count | 112 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.85% in the last 52 weeks. The beta is 1.44, so INO's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | -30.85% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 1.86 |
| Relative Strength Index (RSI) | 50.89 |
| Average Volume (20 Days) | 3,397,951 |
Short Selling Information
The latest short interest is 14.24 million, so 17.37% of the outstanding shares have been sold short.
| Short Interest | 14.24M |
| Short Previous Month | 12.77M |
| Short % of Shares Out | 17.37% |
| Short % of Float | 17.45% |
| Short Ratio (days to cover) | 5.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | -54.21M |
| Operating Income | -83.72M |
| Pretax Income | -84.93M |
| Net Income | -84.93M |
| EBITDA | -82.36M |
| EBIT | -83.72M |
| Earnings Per Share (EPS) | -$1.56 |
Full Income StatementBalance Sheet
The company has $37.68 million in cash and $8.70 million in debt, with a net cash position of $28.99 million or $0.35 per share.
| Cash & Cash Equivalents | 37.68M |
| Total Debt | 8.70M |
| Net Cash | 28.99M |
| Net Cash Per Share | $0.35 |
| Equity (Book Value) | 6.07M |
| Book Value Per Share | 0.07 |
| Working Capital | 1.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$83.35 million and capital expenditures -$226,325, giving a free cash flow of -$83.57 million.
| Operating Cash Flow | -83.35M |
| Capital Expenditures | -226,325 |
| Depreciation & Amortization | 1.36M |
| Net Borrowing | n/a |
| Free Cash Flow | -83.57M |
| FCF Per Share | -$1.02 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -75.88% |
| Shareholder Yield | -75.88% |
| Earnings Yield | -79.74% |
| FCF Yield | -78.46% |
Analyst Forecast
The average price target for INO is $4.50, which is 419.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.50 |
| Price Target Difference | 419.23% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 180.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
